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Abstract
Background: Infections with parasites of the Leishmania donovani complex result in clinical outcomes that range from
asymptomatic infection to severe and fatal visceral leishmaniasis (VL). Neutrophils are major players of the immune
response against Leishmania, but their contribution to distinct states of infection is unknown. Gene expression data
suggest the activation of the NETosis pathway during human visceral leishmaniasis. Thus, we conducted an exploratory
study to evaluate NET-related molecules in retrospective sera from VL patients, asymptomatic individuals and
uninfected endemic controls.
Results: We demonstrate that VL patients and asymptomatic individuals exhibit differential regulation of molecules
associated with neutrophil extracellular traps (NET). These differences were observed at the transcriptional level of
genes encoding NET-associated proteins; in quantifications of cell free DNA and metalloproteinase 9; and in enzymatic
activity of DNAse and elastase. Moreover, multivariate analysis resulted in class-specific signatures, and ROC curves
demonstrate the ability of these molecules in discriminating asymptomatic infection from uninfected controls.
Conclusion: Molecules that are associated with NETs are differentially regulated between distinct states of infection
with L. infantum, suggesting that NETs might have distinct roles depending on the clinical status of infection. Although
unlikely to be exclusive for VL, these signatures can be useful to better characterize asymptomatic infections in
endemic regions of this disease.
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Background
Visceral leishmaniasis (VL) is a life-threatening disease
caused by infections with the protozoan parasites Leish-
mania donovani and L. infantum. It is estimated that over
20,000 deaths occur annually due to VL, however, most
infections remain asymptomatic [1]. The prognosis of
asymptomatic infection and its role in transmission are
unknown; furthermore, the mechanisms underlying either
active VL or asymptomatic infections have not been fully
elucidated. An effective immune response should account
for a favorable outcome after infection, thus asymptomatic
infections can provide important insights towards under-
standing host responses during infections with Leish-
mania [2]. Neutropenia is an independent predictor of
risk of dying from VL [3], whereby systemic inflammation
plays a major role. These findings indicate that neutrophil
activity may be involved in the distinct states of infection;
however, the mechanisms linking neutrophils to active VL
or asymptomatic infection are unknown.
Neutrophils rapidly migrate and infiltrate into sites of
infection and inflammation. They are important sources
of anti-microbial effector molecules involved in host
defense, some of which cause tissue damage. Microbicidal
activity of neutrophils is exerted by proteolytic enzymes,
reactive oxygen species and neutrophil extracellular traps
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(NETs), which exhibit critical roles during infections with
a wide range of pathogens. The release of NETs emerged
as an important process of host response to extracellular
bacteria and fungi [4, 5]; we demonstrated that Leish-
mania also trigger this response [6]: L. donovani and L.
infantum induce release of NETs by human neutrophils,
but they are capable of evading killing through expression
of lipophosphoglycan or 3′-nucleotidase/nuclease activity,
respectively [7, 8]. In spite of this knowledge, the impact
of NETosis during distinct outcomes of human infections
with Leishmania remains unexplored.
Here, we evaluated gene expression data from blood of
VL patients, asymptomatic individuals and uninfected
controls; we observed significant differences between
these groups in the modulation of genes encoding NET-
associated proteins. We also quantified levels of cell-free
DNA and metalloproteinase 9; or measured the enzym-
atic activity of DNAse, elastase and myeloperoxidase in
retrospective sera from distinct states of infection with
L. infantum. We identified profiles that suggest a differ-
ential regulation of NETosis pathway between states of
infection with L. infantum. Importantly, these signatures
point towards novel perspectives for characterization of
asymptomatic infections in endemic areas for VL.
Methods
Study groups
In this study, we used retrospective serum samples
collected from patients with uncomplicated VL at Univer-
sity Hospital, UFS, Aracaju-SE, Brazil (n = 35; male to
female ratio = 1.9; mean age ± standard deviation
(SD) = 31.5 ± 18.3 years), and stored at -80 °C. All samples
were collected before treatment of patients. Diagnosis was
confirmed by identification of Leishmania amastigotes in
Giemsa-stained smears, positive culture on NNN media of
bone marrow aspirate or rK39 positive serology. Retro-
spective serum samples of healthy individuals living in the
same areas were also used. Individuals were tested for de-
layed type hypersensitivity (reflecting cellular immune re-
sponse) and IgG reactivity (reflecting humoral immune
response) to leishmanial antigens as described previously
[9]. Only subjects exhibiting positive reactions to both
tests were considered to be asymptomatically infected
(n = 28; male to female ratio = 1.1; mean
age ± SD = 31.5 ± 15.0 years). Controls included individ-
uals who exhibited negative reactions (n = 25; male to
female ratio = 0.9; mean age ± SD = 30.6 ± 18.1 years).
The groups did not present significant differences with re-
spect to age (tested with ANOVA) or sex distribution
(tested with Chi-square test).
Whole blood transcriptional analyses
Blood collection, RNA extraction, hybridization, scanning
and raw data pre-processing pipeline were described
previously [10]. Differential gene expressions between
distinct groups were identified with linear models and
moderated t-statistic. Differentially expressed genes
(DEGs) were evaluated with GeneGo MetaCore (Thomson
Reuters, NY, USA). P-values were adjusted with
Benjamini-Hochberg, and DEGs or pathway over-
representation were identified by a FDR or q < 0.05. Gene
set enrichment analysis (GSEA) was performed in pre-
ranked list mode with 1000 permutations and weighted
enrichment statistic.
Measurement of extracellular dsDNA
Serum was diluted 1:4 in TE (Tris-HCl 10 mM, pH 8,0;
EDTA 1 mM) and quantified with Quant-iT™ PicoGreen®
dsDNA Assay kit (Thermo Fisher Scientific, Waltham,
USA) as reported previously [6].
DNAse activity assay
NET-DNA enriched supernatants were obtained as de-
scribed previously [5]. Serum was diluted 1:10 and further
incubated with 7 μg/ml of NET-DNA enriched superna-
tants and DNAse cofactors (500 μM CaCl2; 5 mM MgCl2)
at 35 °C and 5% CO2. After 5 h, DNAse activity was calcu-
lated as the percentage of NET-DNA degradation using
Quant-iT™ PicoGreen® dsDNA Assay kit (Thermo Fisher
Scientific, Waltham, USA). Purified DNAse-I (2 units;
Promega, Fitchburg, USA) was used as a positive control
of DNAse activity. Untreated NET-DNA supernatants
were used as reference for calculations.
Elastase, myeloperoxidase (MPO) and metalloproteinase 9
(MMP-9) assays
Serum was diluted 1:4 in buffer (50 mM HEPES, 100
mM NaCl and 0.01% Triton X-100) and elastase activity
was measured with the fluorogenic substrate N-
Methoxysuccinyl-Ala-Ala-Pro-Val-7-amido-4-methyl-
coumarin (Sigma-Aldrich, St. Louis, USA) according to
manufacturer’s instructions. Serum was diluted 1:5 in
PBS 0.5% Hexadecyltrimethylammonium bromide
(5 mg/ml) and peroxidase activity was measured using
3,3′,5,5′-Tetramethylbenzidine (Sigma) after incubation
for 1 h at 35 °C. Absorbance was detected on a Spectra-
Max® Paradigm® microplate reader at 630 nm (Molecular
Devices, California, USA). Quantification of serum
MMP-9 was performed with Human MMP-9 Quantikine
ELISA kit (R&D Systems, Minneapolis, USA) according
to instructions provided by the supplier.
Statistical analysis
One-way ANOVA with Bonferroni’s or Kruskal-Wallis
with Dunn’s multiple comparison tests were applied
to evaluate differences among independent groups.
Spearman’s rank correlation was used to assess non-
parametric associations. P-values less than 0.05 were
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considered significant. Hierarchical clustering was per-
formed with Euclidian distance for metric calculations
and the complete linkage method. Receiver Operating
Characteristic (ROC) curves were generated with the
online analysis platform MetaboAnalyst 3.0 [11], with
PLS-DA as a classification method and t-statistic as a
ranking metric.
Results and discussion
We recently demonstrated that, compared to asymptom-
atic individuals or controls, microarray data expression
from whole blood of VL patients was associated with the
perturbation of several immune related pathways anno-
tated in the GeneGO Metacore database [10]. Diffe-
rentially expressed genes (DEGs, q < 0.05) from VL
patients were enriched in the “NETosis in SLE” pathway
(Additional file 1: Figure S1). To further investigate this
finding, we generated a gene-set termed “NET-associ-
ated proteins”, based on genes coding for proteins
shown to be enriched in NETs released from human
neutrophils with mass spectrometry [5, 12]. GSEA with
DEGs from VL patients pre-ranked by expression fold-
change resulted in significant associations between the
transcriptional profile of VL patients and the “NET-asso-
ciated proteins” gene-set (Fig. 1a, NES = 2.20, P = 0.004
for VL and uninfected controls; NES = 1.80, P = 0.02 for
VL and asymptomatic infection). Indeed, the majority of
genes coding for proteins associated with NETs were up-
regulated in VL patients (Fig. 1a, b). However, compared
to uninfected controls, VL patients exhibited more DEGs
in the core enrichment than compared to asymptomatic
individuals (Fig. 1b). Due the inflammatory nature of
NETs, it is unlikely that this activity of the NETosis
pathway is exclusive for Leishmania infection. Thus, we
evaluated publicly available gene expression profiles
(GEO database) of patients infected with Mycobacterium
tuberculosis (TB), individuals with latent infection with
M. tuberculosis (LTB) and uninfected controls [13]. Of
interest, we also identified differential regulation of
“NET-associated proteins” gene set among the distinct
states of infection with M. tuberculosis (Additional file 2:
Figure S2; NES = 2.77, P < 0.0001 for TB and uninfected
controls; NES = 2.06, P < 0.0001 for TB and LTB). Taken
together, those findings suggest that expression profiles
might reflect the activity of the NETosis pathway during
infections, and might be differentially regulated between
active disease and asymptomatic status as demonstrated
for other immune compartments such as antibody pro-
files in tuberculosis [14] and VL [9], and transcriptional
activity of type I interferon responses in VL [10].
To investigate further, we screened sera for known
components of NETs in a retrospective cohort of sub-
jects presenting with distinct statuses of infection with
L. infantum. We quantified levels of cell free DNA and
matrix metalloproteinase 9 (MMP-9), and measured the
enzymatic activity of DNAse, elastase and myeloperoxi-
dase (MPO). Compared to uninfected controls, levels of
DNA were elevated in sera from VL patients and asymp-
tomatic individuals (Fig. 1c, H = 18.43, df = 2, P < 0.0001).
The degradation of NET-DNA, reflecting the enzymatic
activity of DNAse, was also elevated in sera from VL pa-
tients and asymptomatic controls (Fig. 1c,H = 13.76, df = 2,
P = 0.001). In contrast, the levels of MMP-9 were reduced
in VL patients compared to both asymptomatic and unin-
fected controls (Fig. 1c, H = 25.15, df = 2, P < 0.0001),
which did not differ between these two groups, as
reported [15]. Surprisingly, the enzymatic activity of elas-
tase was elevated in asymptomatic individuals, compared
to both VL patients and uninfected controls (Fig. 1c, H =
20.12, df = 2, P < 0.0001), but VL and uninfected controls
did not differ. Although a tendency for increased activity
of MPO was observed for sera of asymptomatic individ-
uals, there was not significant difference between the
groups. Correlation analysis revealed a positive association
between levels of DNA and elastase activity in sera from
VL patients (Fig. 1d, r = 0.5, P = 0.03). Of note, levels of
DNA in sera from asymptomatic individuals correlated
negatively with activity of DNAse (Fig. 1d, r = -0.6, P =
0.03). Moreover, activity of DNAse and MPO were nega-
tively correlated for VL patients (r = -0.5, P = 0.04). The
lack of correlations between NET-associated molecules
should be considered suggestive that the activity of those
molecules might have a different origin than neutrophils.
However, we speculate that the constitution and/or activ-
ity of the NETosis pathway could depend on the state of
infection, as different stimulus can impact NET protein
composition [16]. Whether the differential regulation be-
tween those molecules is indeed resulting from the release
of NETs still needs detailed investigation. In this context,
recent work demonstrated that VL patients present ele-
vated levels of plasma arginase, MPO and elastase, which
return to baseline levels after treatment, however asymp-
tomatic infections were not analyzed [17]. We evaluated
chronically infected individuals that should be carrying
intracellular forms of Leishmania, raising questions about
of the role of extracellular traps in asymptomatically in-
fected and diseased subjects. One explanation could be
that when amastigotes emerge from their niches to invade
other cells they become susceptible to the activity of
NETs. Recently, we reported an intimate association of
extracellular amastigotes with NETs in cutaneous leish-
maniasis lesions [18]. The spontaneous release of NETs
plays an important role in several inflammatory diseases
[16], giving another perspective to NETs in infections with
L. infantum: spontaneous release of NETs during chronic
VL could induce and/or maintain a systemic inflammatory
response, contributing to the pathology of the disease. In a
previous study, neutrophils from VL patients exhibited
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impaired release of NETs during stimulations in vitro [17].
However, the inflammatory environment to which neutro-
phils are submitted during the course of an infection has
profound effects on neutrophils functions [19], and needs
to be accounted for. Our study was limited to retrospect-
ive sera samples collected previously [9], but our data pro-
vide a proof of principle that the NETosis pathway can be
important and should be investigated with more details in
VL and asymptomatic infections. While neutrophil counts
might also influence the quantification of the molecules
evaluated herein, we highlight the fact that despite re-
duced proportions of granulocytes, VL patients still exhib-
ited high activity of the NETosis pathway at the
transcriptional level [10].
Next, we conducted principal components analysis
(PCA) to identify profiles of expression data of genes
coding for NET-associated proteins or of serum indica-
tors of NETosis from the groups of study. We observed
a clear clustering pattern in expression data from VL pa-
tients and, as expected, those of asymptomatic
Fig. 1 Changes in transcriptional and functional activity of indicators of NETosis depend on the outcome of infection with Leishmania infantum. a
Gene set enrichment analysis (GSEA) showing statistically significant enrichment of differentially expressed genes from VL patients in the “NET-
associated proteins” gene-set (FDR = false discovery rate). b Heat map displaying log2 fold changes of genes in the “core enrichment” identified
by GSEA. c Levels of serum DNA and matrix metalloproteinase 9 (MMP-9) or activity of DNAse, elastase and myeloperoxidase (MPO) are shown
for endemic controls (EC; green circles), asymptomatic individuals (ASYMP; blue squares) and VL patients (VL; red triangles). Data were analyzed with
ANOVA with Bonferroni’s or Kruskal-Wallis with Dunn’s multiple comparison test. Lines represent mean or median values. d Correlations between
serum DNA, elastase activity, DNAse activity and MPO activity. Spearman’s rank correlation was used to assess significant associations for EC
(n = 9), ASYMP (n = 10) and VL (n = 13). Significance is given *P < 0.05, **P < 0.01 and ***P < 0.001
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individuals and uninfected controls were not distinguish-
able (Fig. 2a). Unfortunately, we were unable to perform
all the serum assays for each of the subjects enrolled in
the study, however, for a subset of individuals the ana-
lysis of principal components with indicators of NETosis
revealed a successful segregation of subjects from dis-
tinct states of infection (Fig. 2b, left panel). Therefore, to
gain power in the analysis by increasing the number of
individuals from each group, we excluded measurements
from MMP-9 and again found a consistent clustering
pattern among subjects of specific groups (Fig. 2b, right
panel). We next performed PCA based on peer-
comparisons between the groups of study that confirmed
distinct profiles of serum indicators of NETosis (Fig. 2c).
To characterize the contribution of those molecules to
distinct profiles between asymptomatic infection and ac-
tive VL, we performed an unsupervised hierarchical clus-
tering that retrieved biosignatures with the ability to
discriminate between states of infection (Fig. 2d). Of
note, asymptomatic individuals present an overall in-
crease in levels of serum DNA and activity of MPO and
elastase, while VL patients exhibit a strong signature of
the activity of DNAse (Fig. 2d). Clustering of subjects in
distinct groups, in addition to their original
Fig. 2 Indicators of NETosis compose biosignatures that discriminate distinct states of infection with Leishmania infantum. a Principal components
analysis (PCA) based on expression data from genes included in the “NET-associated proteins” gene-set for endemic controls (EC; green), asymptomatic
individuals (ASYMP; blue) and VL patients (VL; red). b PCA based on serum indicators of NETosis. Left-panel included measurements for levels of serum
DNA and metalloproteinase 9 (MMP-9); and activity of DNAse, elastase and myeloperoxidase (MPO) from serum of EC (n = 3), ASYMP (n = 5) and VL
(n = 4). Right-panel included measurements for levels of serum DNA; and activity of DNAse, elastase and myeloperoxidase (MPO) from serum of EC
(n = 9), ASYMP (n = 10) and VL (n = 13). c PCA based on serum indicators of NETosis, excluding measurements for MMP-9. Left-panel depicts analysis
for EC (n = 9) and VL (n = 13). Middle-panel depicts analysis for EC (n = 9) and ASYMP (n = 10). Right-panel depicts analysis for ASYMP (n = 10) and VL
(n = 13). d Unsupervised hierarchical clustering of serum indicators of NETosis, depicted for ASYMP (n = 10) and VL (n = 13) including activity of DNAse
(NET-DNA degradation %); activity of myeloperoxidase (MPO); activity of elastase and serum DNA. e Unsupervised hierarchical clustering of serum
indicators of NETosis, depicted for ASYMP (n = 10) and EC (n = 9) including activity of DNAse (NET-DNA degradation %); activity of myeloperoxidase
(MPO); activity of elastase and serum DNA. Analysis was performed with Euclidian distance for metric calculations and the complete linkage method.
f ROC curves comparing three predictive models using 2, 3 or 4 features between asymptomatic individuals and endemic controls
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classification, suggests that the molecular signatures
identified herein could also help in the design of progno-
sis scores, leading to a faster identification of individuals
prone to develop VL and facilitate planning of treat-
ments. For that purpose, longitudinal studies following
asymptomatic carriers during a substantial period of
time after infection might be useful to understand the
relationship between molecular signatures of NETs and
turnover of clinical status.
More striking was the observation that signatures
composed by NET-related molecules distinguish
asymptomatic individuals from uninfected controls
(Fig. 2e). Most biomarkers of infection with Leishmania
and diagnostic assays have been evaluated for their cap-
acity to detect clinical disease, whereas the absence of
robust markers for asymptomatic infection remains a
problem [2]. Identification of these individuals is time
consuming, expensive, and the availability of appropri-
ate leishmanial antigens to performed DTH tests is
often limited. The investigation of asymptomatic infec-
tions remains largely neglected, but can provide signifi-
cant information to understand the immunobiology of
VL [2]. NETosis is not an exclusive process for infec-
tions with Leishmania, and our data do not point for
biomarkers of active VL. Moreover, an ideal biomarker
exhibits unique associations with a particular pheno-
type. However, these molecular signatures might con-
tribute to a better characterization of asymptomatic
infection. This can be particularly useful in settings
where only one method of characterization is available
in endemic regions for VL. To support this concept,
ROC curves were generated to verify the predictive
value of these molecules in distinguishing asymptom-
atic L. infantum infection from uninfected individuals
(Fig. 2f ). By comparing models with varying numbers of
features, the model with the 4 features exhibit the lar-
gest area under the curve (AUC - 0.948) and highest
predictive accuracy value of 90.6%. This multivariate
approach might reflect better the activity of the NETo-
sis pathway in comparison to univariate analyses.
Nevertheless, further investigation with larger numbers
of individuals, and longitudinal designs will be neces-
sary to validate these findings.
Conclusions
In summary, our study prompts a more comprehensive
evaluation of NETs during distinct states of infection
with Leishmania. The signatures identified herein raise
the hypothesis that NETs can play distinct roles depend-
ing on the progression of the infection. Of importance,
the predictive value of these signatures point for novel
directions to better characterize asymptomatic infections
in endemic areas for VL.
Additional files
Additional file 1: Figure S1. “NETosis in SLE” pathway map generated
with GeneGO Metacore. Colored asterisks indicate differentially expressed
genes of VL patients compared to uninfected controls, where red indicates
upregulated genes and blue indicates downregulated genes. See MetaCore
website for detailed legend at https://portal.genego.com/legends/
MetaCoreQuickReferenceGuide.pdf. (TIFF 2787 kb)
Additional file 2: Figure S2. Gene set enrichment analysis (GSEA)
showing statistically significant enrichment of differentially expressed
genes from patients infected with Mycobacterium tuberculosis in the “NET-
associated proteins” gene-set (FDR = false discovery rate). M. tuberculosis
patients (TB), uninfected controls (CTRL) and latent M. tuberculosis infection
(LTB). (TIFF 785 kb)
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